Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
RESEARCH TOOLSreports
Total Valuation
BioStem Technologies has a market cap or net worth of $231.43M. The enterprise value is ―.
Market Cap$231.43M
Enterprise Value―
Share Statistics
BioStem Technologies has 16,338,436 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,338,436
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioStem Technologies’s return on equity (ROE) is 6.31 and return on invested capital (ROIC) is -226.80%.
Return on Equity (ROE)6.31
Return on Assets (ROA)-0.58
Return on Invested Capital (ROIC)-226.80%
Return on Capital Employed (ROCE)7.33
Revenue Per Employee8.34M
Profits Per Employee-4.24M
Employee Count2
Asset Turnover1.15
Inventory Turnover1.92
Valuation Ratios
The current PE Ratio of BioStem Technologies is -9.47. BioStem Technologies’s PEG ratio is 0.13.
PE Ratio-9.47
PS Ratio0.00
PB Ratio6.53
Price to Fair Value-59.75
Price to FCF10.21
Price to Operating Cash Flow10.00
PEG Ratio0.13
Income Statement
In the last 12 months, BioStem Technologies had revenue of 16.69M and earned -8.48M in profits. Earnings per share was -0.62.
Revenue16.69M
Gross Profit15.42M
Operating Income-7.78M
Pretax Income-8.48M
Net Income-8.48M
EBITDA-7.55M
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was 14.91M and capital expenditures -295.24K, giving a free cash flow of 14.61M billion.
Operating Cash Flow14.91M
Free Cash Flow14.61M
Free Cash Flow per Share0.89
Dividends & Yields
BioStem Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.97
52-Week Price Change94.56%
50-Day Moving Average11.97
200-Day Moving Average13.16
Relative Strength Index (RSI)63.01
Average Volume (3m)68.58K
Important Dates
BioStem Technologies upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
BioStem Technologies as a current ratio of 0.81, with Debt / Equity ratio of 19.62%
Current Ratio0.81
Quick Ratio0.76
Debt to Market Cap0.06
Net Debt to EBITDA-0.60
Interest Coverage Ratio-11.11
Taxes
In the past 12 months, BioStem Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioStem Technologies EV to EBITDA ratio is -11.23, with an EV/FCF ratio of -23.54.
EV to Sales5.09
EV to EBITDA-11.23
EV to Free Cash Flow-23.54
EV to Operating Cash Flow-24.25
Balance Sheet
BioStem Technologies has $14.61M in cash and marketable securities with $4.48M in debt, giving a net cash position of -$10.13M billion.
Cash & Marketable Securities$14.61M
Total Debt$4.48M
Net Cash-$10.13M
Net Cash Per Share-$0.62
Tangible Book Value Per Share-$0.14
Margins
Gross margin is 94.76%, with operating margin of -46.62%, and net profit margin of -50.84%.
Gross Margin94.76%
Operating Margin-46.62%
Pretax Margin-50.84%
Net Profit Margin-50.84%
EBITDA Margin-45.27%
EBIT Margin-46.64%
Analyst Forecast
The average price target for BioStem Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast473.06%
EPS Growth Forecast―